Jump to content
RemedySpot.com

The Value of Studies

Rate this topic


Guest guest

Recommended Posts

More studying of for the value of T3 is not needed as bad as knowing that T3

does not work for everybody. Why? According to Sir Karl Popper's widely

accepted philosophy on science, a science must first be testable and second must

not have any counterexamples. In otherwords, it must be falsifiable but not

falsified.

So where does that leave studies? If these studies falsify the endocrinology

paradigm, they are only useful in these days of providing court evidence in

courts that adhere to the Popper inspired Daubert Rule. While the US federal

courts do and many state courts do, the UK is not one yet. After those arenas,

we are left with the old Frey rule or " general concensus, " which medicine uses

still to this day.

The Daubert Rule was created by the US Supreme Court to not allow evidence of

junk science. However, medicine still allows junk science. Consequently,

corrupted influential physicians can get junk science approved by " general

concensus " whereas it would fail under closer scrutiny of the Daubert Rule.

What is really necessary is counterexamples who are willing to testify to their

poor experience with T4-only and good experience with T3. And then, the studies

will have a chance. Otherwise, like Dr. Marshall Goldberg's paper on Euthyroid

Hypometabolism, they will be swept under the corrupt rug.

Have a great day,

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...